Beth Hecht - 15 Jun 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Beth Hecht
Issuer symbol
ITRM
Transactions as of
15 Jun 2022
Net transactions value
+$2,378
Form type
4
Filing time
17 Jun 2022, 17:02:04 UTC
Previous filing
22 Mar 2022
Next filing
24 Jun 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Award $2,378 +237,795 $0.0100* 237,795 15 Jun 2022 Ordinary Shares 237,795 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.
F2 Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on June 15, 2023.